Key facts
- This page summarizes David J. Katzoff's Form 4 filing for Alzamend Neuro, Inc. (ALZN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Mar 2025, 07:30.
David J. Katzoff - 21 Mar 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ALZN
- Reported as of
- 21 Mar 2025
- Net transaction value
- +$5,048
- SEC form
- 4
- Accepted by SEC
- 24 Mar 2025, 07:30:07 UTC
- Prior SEC filing
- 26 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David J. Katzoff
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David J. Katzoff filed Form 4 for Alzamend Neuro, Inc. (ALZN) on 24 Mar 2025.
Change
- Previous filing in this sequence was filed on 26 Sep 2023.
- Current net transaction value: +$5,048.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALZN
transaction
Common Stock
Purchase
- Transaction value
- $5,048
- Shares
- +5,000
- Change %
- +926%
- Price
- $1.01
- Shares after
- 5,540
- Date
- 21 Mar 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.